Article
Cover
RNJPH Journal Cover Page

RGUHS Nat. J. Pub. Heal. Sci Vol No: 9  Issue No: 3 eISSN: 2584-0460

Article Submission Guidelines

Dear Authors,
We invite you to watch this comprehensive video guide on the process of submitting your article online. This video will provide you with step-by-step instructions to ensure a smooth and successful submission.
Thank you for your attention and cooperation.

Original Article

Mohamed Tanveer Ahmed1 , Vanitha B2 , Riyaz Basha S3 , Jagadish4

1: Assistant Professor, 2: Senior Resident, 3: Professor & Head, 4: Statistician Dept of Community Medicine, Sri Atal Bihari Vajpayee Medical College and Research Institute, Bangalore, Karnataka.

*Corresponding author: Dr. Vanitha B, Senior Resident, Dept of Community Medicine, Bowring & Lady Curzon Medical College & Research Institute, Shivajinagar, Bengaluru - 560002. Email ID: vanisonu1510@gmail.com Affiliated to Rajiv Gandhi University of Health Sciences, Bengaluru, Karnataka.

Received: April 7, 2021; Accepted: May 24, 2021; Published: June 30, 2021

Received Date: 2021-04-07,
Accepted Date: 2021-05-24,
Published Date: 2021-06-30
Year: 2021, Volume: 6, Issue: 2, Page no. 35-39, DOI: 10.26463/rnjph.6_2_3
Views: 1428, Downloads: 14
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

Background: COVID–19 is a pandemic that was first reported in Wuhan city of China in December 2019. This disease is caused by a novel coronavirus which was subsequently named SARS-CoV-2 and is a “GLOBAL HEALTH EMERGENCY” with a high magnitude crossing all the international borders, involving a large geographical area, affecting millions of people leading to disabilities and deaths. The catastrophic effect of this disease has ruined lives in many forms, thereby hampering the quality of life.

Objectives: To assess the epidemiological and clinical profile of COVID–19 suspects in a teaching hospital of Bangalore Urban district.

Methodology: Data of outpatients and inpatients who presented to Bowring & Ghosha Hospital as COVID–19 suspects as per international guidelines during the specific time period of the pandemic was included in the study from electronic records of the hospital. Suitable statistical methods were used to analyze the data wherever necessary.

Results: 42% of them had contact history and 39% of them were asymptomatic and the positivity rate was 25%. 47% of them were diagnosed to have Severe Acute Respiratory Infection (SARI) and 31% of them had Influenza Like Illness (ILI). There was a significant association between age, sex, co-morbidities, contact history, and type of case with unfavourable outcome. Conclusion: The study findings could be used to plan further management of COVID-19 as there is a rapid surge in the disease trend.

 

<p><strong>Background:</strong> COVID&ndash;19 is a pandemic that was first reported in Wuhan city of China in December 2019. This disease is caused by a novel coronavirus which was subsequently named SARS-CoV-2 and is a &ldquo;GLOBAL HEALTH EMERGENCY&rdquo; with a high magnitude crossing all the international borders, involving a large geographical area, affecting millions of people leading to disabilities and deaths. The catastrophic effect of this disease has ruined lives in many forms, thereby hampering the quality of life.</p> <p><strong>Objectives:</strong> To assess the epidemiological and clinical profile of COVID&ndash;19 suspects in a teaching hospital of Bangalore Urban district.</p> <p><strong>Methodology:</strong> Data of outpatients and inpatients who presented to Bowring &amp; Ghosha Hospital as COVID&ndash;19 suspects as per international guidelines during the specific time period of the pandemic was included in the study from electronic records of the hospital. Suitable statistical methods were used to analyze the data wherever necessary.</p> <p><strong>Results:</strong> 42% of them had contact history and 39% of them were asymptomatic and the positivity rate was 25%. 47% of them were diagnosed to have Severe Acute Respiratory Infection (SARI) and 31% of them had Influenza Like Illness (ILI). There was a significant association between age, sex, co-morbidities, contact history, and type of case with unfavourable outcome. Conclusion: The study findings could be used to plan further management of COVID-19 as there is a rapid surge in the disease trend.</p> <p>&nbsp;</p>
Keywords
Novel COVID-19, Disease pattern, Pandemic
Downloads
  • 1
    FullTextPDF
Article

Introduction

COVID–19 is a pandemic that was first reported in Wuhan city of China by WHO on 31st December 2019. This disease is caused by a novel Coronavirus which was subsequently named SARS-CoV- 2. It is a form of beta coronaviruses associated with human severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS).1

It is a disease with a high magnitude crossing all the international borders, involving a large geographical area, affecting millions of people leading to disabilities and deaths. The catastrophic effect of this disease has ruined the lives in many forms, thereby hampering the quality of Life.2

This disease which was initially assumed as an outbreak of pneumonia with symptoms such as fever, cough, and difficulty in breathing resulted in severe acute respiratory distress leading to respiratory failure. As per the situation report – 110 of World Health organization on COVID–19, there are about 3.8 lakh cases of COVID–19 all over the world with 2.6 lakh deaths.3

After spreading rapidly in China, infecting approximately 85,000 people, it had spread to Europe causing massive loss of life and property which compelled the World Health Organization to declare COVID –19 as a global pandemic on 11th March 2020.4 Before 3rd March 20204, India had three cases of coronavirus in Kerala, followed by fourth case in Rajasthan who had infected few of the foreigners who were on Indian tour.5 Gradually the number of cases increased in India too.

Therefore, this study was considered to determine the epidemiological and clinical profile of COVID-19 suspects in terms of age, sex, clinical symptoms, travel history, contact with a laboratory-confirmed case of those who were admitted to a tertiary health care facility of Bangalore Urban district. Therefore, this study was conducted to evaluate the epidemiological and clinical profile of COVID-19 suspect cases treated in a teaching hospital of Bangalore Urban district and to assess the association between outcome and clinicalepidemiological profile of COVID-19 suspects.

Material and methods

A cross-sectional study was conducted for a period of three months from March 2020 – July 2020, where almost 1700 COVID suspect cases of all ages who presented to the hospital were included. COVID-19 suspects were defined as those having fever/cold/Influenza-like illness or contacts of Reverse Transcription Polymerase Chain Reaction ( RT-PCR) positive individuals. Patients walking into tertiary care setup as COVID-19 disease suspects were investigated for RT-PCR and were either admitted or sent for home quarantine based on clinical assessment. The admitted patients were discharged/ quarantined/referred based on the test results and clinical severity. All the above patients were included in the study during the study period. 

Ethical approval for the study was obtained from the institutional ethics committee. Data was obtained from the hospital e-records after taking permission from hospital authorities. MS Excel was used to enter the data and was analyzed using statistical software SPSS version 20.0.

Data was expressed in percentages, mean and standard deviation wherever necessary and presented in the form of tables. Chi-square test was used to assess the association between variables and positive report for RTPCR test.

Results

A total of 1720 COVID-19 suspect cases were included in the study. The mean age of the study participants was 37.12 (15.8) years.  

About 1148 (66.8%) of the participants belonged to the age group of 18-44 years. Among them, 190 (11%) were elderly above the age of 60 years and 63 (3.7%) were below the age of 18 years. The majority 1110 (64.5%) of them were males. 55 (3.2%) of them had travel history and 730 (42.4%) of them had contact history. The same is shown in Table 1.

Among 730 individuals who had contact history, 370 (50.7%) of them were primary contacts and 334 (45.8%) of them were healthcare workers. The details of contact history are described in Table 2.

About 671 (39.0%) of them were symptomatic and 371 (21.6%) were having co-morbidities. 344 (20.0%) of them were classified as having Severe Acute Respiratory Illness (SARI) and 222 (12.9%) as having Influenza-like illness (ILI).

When all the suspects were tested for RT-PCR COVID-19 test, 427 (24.8%) of them were positive. Out of those who tested negative, about 996 (57.9%) were admitted. The same is depicted in Table 3.

Among 671 participants who had symptoms, 376 (56%) had fever, cough and cold which were the predominant symptoms reported. 125 (18.6%) of them reported breathlessness and 81 (12.1%) reported cough/cold/sore throat. About 100 (26.9%) of them had both diabetes and hypertension. The same has been depicted in Table 4.

Among 724 admissions, 50 (6.9%) had unfavourable outcome (death). There was a significant association found between age, sex, travel history, contact history and type of case with unfavourable outcome. The same is depicted in Table 5.

Discussion

Treating COVID suspects during the initial phase of the pandemic was an important task to identify contacts and high-risk individuals for the necessary process. The above study evaluated the clinico-epidemiological profile of suspects treated in tertiary care hospital. Among 1720 COVID suspects, 42% had contact history and 39% were asymptomatic. The positivity rate was 25% and 42% of them were admitted for treatment.

Khan M et. al,6 conducted a study to describe epidemiological and clinical characteristics of COVID-19 cases at a screening clinic in the year 2020. The positivity rate among the suspects was 14.3% which was less compared to our study. Fever, cough and cold were the commonest symptoms similar to our study findings. 18% of them showed travel history. However, in our study only 7.3% of them had travel history. 

Escosteguy CC et al,7 in their study conducted in the year 2020 assessed the factors associated with death among the COVID suspects and showed age as a significant factor to cause death among the suspects. The same was observed in our study and was statistically significant

Owusu M et al,8 conducted a study to describe the epidemiological profile of SARS-CoV-2 among selected regions in Ghana. They stated that among suspects, 13.2% were positive which was less when compared to our study. Males showed a higher positivity rate similar to the findings of our study.

Gupta N et al,9 conducted a study in 2020 to report the epidemiologic and clinical features of initial 21 patients and reported that 62% of the patients had recent travel history, which was 10 times more than our study. The most common symptoms reported were fever and cough (42.9%) followed by sore throat, headache and breathlessness similar to the findings of our study.

The larger sample size tried to predict the actual scenario during the initial days. However, it cannot be generalized to the entire population as it is limited to hospital settings. The data source was limited to e-record findings and lacks the certainty of findings.

Conclusion and Recommendations

42% of them had contact history and 39% of them were asymptomatic and the positivity rate was 25%. 47% of them were diagnosed to have SARI and 31% of them had ILI. There was a significant association between age, sex, co-morbidities, contact history, and type of case with unfavourable outcome. The study findings could be used to plan further management of COVID-19 as there is a rapid surge in the disease trend.

 

Supporting File
No Pictures
References
  1.  Zheng J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci 2020;16(10):1678-1685. Available from: https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC7098030/ 
  2. A virus that respects no borders: protecting refugees and migrants during COVID-19 [Internet]. Who.int. 2021. Available from: https://www.who.int/newsroom/feature-stories/detail/a-virus-that-respectsno-borders-protecting-refugees-and-migrantsduring-covid-19 
  3. WHO corona virus (COVID 19) Dashboard [Internet]. World Health Organization. Available from: https://covid19.who.int/ 
  4. Coronavirus disease (COVID-19) pandemic. [Internet]. World Health Organization. Available from: https://www.who.int/emergencies/diseases/ novel-coronavirus-2019 
  5. Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update [Internet]. World Health Organization. Available from: https://www.who.int/emergencies/ diseases/novel-coronavirus-2019/situation-reports 
  6. Khan M, Khan H, Khan S, Nawaz M. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-Centre study. J Med Microbiol 2020;69:1114–1123. doi: 10.1099/ jmm.0.001231. 
  7. Escosteguy CC, Eleuterio TA, Pereira AGL, Marques MRVE, Brandao AD, Batista JPM. COVID-19: a cross-sectional study of suspected cases admitted to a federal hospital in Rio de Janeiro, Brazil, and factors associated with hospital death. Epidemiol Serv Saude 2020;30(1):e2020750. 
  8. Owusu M, Sylverken AA, Ankrah ST, El Duah P, Ayisi-Boateng NK, Yeboah R, et al. (2020). Epidemiological profile of SARS CoV-2 among selected regions in Ghana: A cross-sectional retros pective study. PLoS One 2020; 15(12): e0243711. 
  9. Gupta N, Agrawal S, Ish P, Mishra S, Gaind R, Usha G et al. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Arch Chest Dis 2020;90:1294. 
HealthMinds Logo
RGUHS Logo

© 2024 HealthMinds Consulting Pvt. Ltd. This copyright specifically applies to the website design, unless otherwise stated.

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.